// App-Quantinova.ai

TCT-123 : Pressure-Controlled Intermittent Coronary Sinus Occlusion Reduces Infarct Size After primary PCI: A propensity-controlled matched study

Researchers

Presenter

  • MOHANED EGRED

Principal Investigators

  • Roger Kessels

  • Alan Bagnall

  • Ioakim Spyridopoulos

  • Nick Palmer

  • Ever Grech

  • Ajay Jain

  • Gregg Stone

  • Robin Nijveldt

  • Thomas McAndrew

Medical Centers

  • Cardiovascular Research Foundation, New York, New York, United States

  • Radboudumc, Nijmegen, Netherlands

  • Northern General Hospital, Sheffield, United Kingdom

  • Newcastle University, Newcastle upon Tyne, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • Barts Heart Centre, London, United Kingdom

  • The Liverpool Heart and Chest Hospital, Liverpool, United Kingdom

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

Locations

  • United States

  • Netherlands

  • United Kingdom

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved